Assenagon Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-162,559
| Closed | -$1.73M | – | 1373 |
|
|
2023
Q2 | $1.73M | Buy |
162,559
+5,055
| +3% | +$53.8K | 0.01% | 812 |
|
|
2023
Q1 | $1.66M | Buy |
157,504
+20,575
| +15% | +$216K | 0.01% | 882 |
|
|
2022
Q4 | $1.7M | Sell |
136,929
-10,707
| -7% | -$133K | 0.01% | 829 |
|
|
2022
Q3 | $1.53M | Buy |
147,636
+11,527
| +8% | +$119K | 0.01% | 767 |
|
|
2022
Q2 | $1.57M | Buy |
+136,109
| New | +$1.57M | 0.01% | 904 |
|
|
2022
Q1 | – | Sell |
-193,514
| Closed | -$2.26M | – | 1438 |
|
|
2021
Q4 | $2.26M | Sell |
193,514
-63,200
| -25% | -$737K | 0.01% | 746 |
|
|
2021
Q3 | $3.35M | Sell |
256,714
-20
| -0% | -$261 | 0.01% | 501 |
|
|
2021
Q2 | $3.3M | Hold |
256,734
| – | – | 0.01% | 542 |
|
|
2021
Q1 | $2.87M | Buy |
+256,734
| New | +$2.87M | 0.01% | 600 |
|